Genetec Technology (0104) Fundamentals 2026 — Revenue Analysis | SniperIQ
Genetec Technology (0104) is a MY-listed Industrials company in Industrial - Machinery with a market capitalization of RM259M, trading at RM0.34 on the KLS. This SniperIQ fundamentals page covers Genetec Technology's valuation, profitability (net margin -139.3%), revenue (RM125M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Genetec Technology's market cap?
Genetec Technology (0104) has a market capitalization of approximately RM259M, trading at RM0.34 on the KLS. Market cap moves with the live share price.
What is Genetec Technology's P/E ratio?
Genetec Technology's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.9x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Genetec Technology?
Genetec Technology runs a net profit margin of -139.3%, a gross margin of -93.2%, and an operating margin of -103.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Genetec Technology generate?
Genetec Technology reported revenue of RM125M for fiscal year 2025, with net income of -RM175M and earnings per share (EPS) of -0.22. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Genetec Technology pay a dividend?
Genetec Technology does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Genetec Technology financially healthy?
Genetec Technology carries a debt-to-equity ratio of 0.35x and a current ratio of 2.13x, with a market beta of 0.24. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Genetec Technology a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Genetec Technology (0104) the key facts are: market cap RM259M, revenue RM125M, 52-week range 0.145-0.8. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Genetec Technology's full fundamentals live
Get Genetec Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.